antigenic英 ['æntɪdʒɪenɪk] 美 ['æntɪdʒɪenɪk]
adj. 抗原的；抗原性的
发音：/ˌæntɪˈdʒenɪk/
用法：用作形容词，表示“抗原的；抗原性的”。
分别的发音：/ˌæntɪdʒɪnɪk/
分别的单词意思：adj. 分开的；分别的；各自的；n. 分别；分居。
分别的用法：在句子中可作形容词、名词和动词。例如，The two groups of people were separated by a barrier of their own making. (作形容词)这两组人被人为制造的障碍物隔开了。The two countries have separate interests and goals. (作名词)这两个国家的利益和目标各不相同。The soldiers were ordered to separate the combatants from the civilians. (作动词)士兵们被命令把战斗人员和老百姓分开。
分别的记法：可以结合具体的语境来记忆，也可以通过造句来加深记忆。
antigenic（抗原性的）是一种生物学现象，指能够刺激机体产生免疫应答，并能与免疫应答产物抗体和/或致敏淋巴细胞结合发生特异性免疫反应的物质。抗原的基本特性是免疫原性和免疫反应性。抗原物质能刺激机体产生免疫应答是由于它们具有特殊的分子结构，特别是它们带有某些能与免疫活性细胞表面分子（如MHC分子）发生相互作用的特殊化学基团，当抗原与抗体发生特异性结合形成免疫复合物时，就会产生各种生物学效应。
在物理现象中，抗原性可能表现为物质在特定物理条件下表现出的特性或行为。例如，某些物质在特定的温度、压力、电场、磁场等条件下可能表现出特定的物理变化，如熔化、汽化、磁化等，这些变化可以被认为是物质表现出的抗原性。
需要注意的是，抗原性的具体表现和意义会因具体情境而异，需要结合具体的物理和化学环境来理解。
Antigenic Management: A Key to Success in Biotechnology
Antigenic management is a crucial aspect of biotechnology that has gained increasing attention in recent years. It involves the identification, selection, and optimization of antigens to ensure that they are effective, safe, and immunogenic. In this article, we will explore the importance of antigenic management and discuss its implications for biotechnology companies and their stakeholders.
Antigens are proteins or peptides that serve as targets for the immune system. They are critical for vaccine development, as they stimulate the production of antibodies that protect against diseases. However, antigens can be challenging to manage effectively, as they must strike a balance between immunogenicity (ability to stimulate an immune response) and safety (minimizing adverse effects).
The first step in antigenic management is to identify potential antigens through research and development activities. This involves studying the biology of the target pathogen and identifying antigens that are highly immunogenic and stable during manufacturing processes. The next step is to select antigens that are suitable for clinical trials based on their safety and immunogenicity profiles.
Once antigens have been selected, it is important to optimize their production and purification processes to ensure consistent quality and yield. This requires a comprehensive understanding of the manufacturing process, including the use of advanced technologies such as high-throughput screening and automation. Optimization of antigen production and purification also ensures that the final product meets regulatory standards and is cost-effective for commercialization.
Antigenic management also involves ensuring that the final product is safe for use in humans. This requires strict quality control measures, including testing for purity, identity, and stability of the antigen. In addition, it is essential to monitor the safety of the vaccine during clinical trials to ensure that any adverse effects are minimal and manageable.
Finally, antigenic management has implications for biotechnology companies and their stakeholders. By effectively managing antigens, companies can reduce the risk of failure in clinical trials and ensure that their vaccines are safe and effective. This ultimately leads to increased market acceptance and profitability for the company.
In conclusion, antigenic management is a crucial aspect of biotechnology that must be carefully managed to ensure that vaccines are safe, effective, and immunogenic. By optimizing antigen production and purification processes, monitoring safety, and ensuring regulatory compliance, biotechnology companies can achieve success in this rapidly growing field.